ARYX Insider Trading Activity and SEC Form 4 Filings
ARYX insider trading summary
No open-market insider purchases or sales of ARYx Therapeutics, Inc. (ARYX) have been reported on SEC Form 4 in the past 12 months.
Latest ARYX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 10, 2011 | Scott D Sandell | 10% Owner | Sell | $326K (4,469,274 @ $0.07) |
| Mar 10, 2011 | Charles W Newhall III | 10% Owner | Sell | $326K (4,469,274 @ $0.07) |
| Mar 10, 2011 | C Richard Kramlich | 10% Owner | Sell | $326K (4,469,274 @ $0.07) |
| Mar 10, 2011 | Growth Equity Opportunities Fund, LLC | 10% Owner | Sell | $326K (4,469,274 @ $0.07) |
| Mar 10, 2011 | New Enterprise Associates 12, Limited Partnership | 10% Owner | Sell | $326K (4,469,274 @ $0.07) |
| Mar 10, 2011 | Nea 12 Gp, LLC | 10% Owner | Sell | $326K (4,469,274 @ $0.07) |
| Mar 10, 2011 | Mark W Perry | 10% Owner | Sell | $326K (4,469,274 @ $0.07) |
| Mar 10, 2011 | M James Barrett | 10% Owner | Sell | $326K (4,469,274 @ $0.07) |
| Mar 10, 2011 | NEA Partners 12, Limited Partnership | 10% Owner | Sell | $326K (4,469,274 @ $0.07) |
| Mar 10, 2011 | Peter J Barris | 10% Owner | Sell | $326K (4,469,274 @ $0.07) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.